StreetInsider.com News Articles

Form 8-K BioNexus Gene Lab Corp For: Oct 05

Wed, 07 Oct 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20261007/27158950.html

BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence

Wed, 07 Oct 2026 08:30:00 -0400

Licence of up to 20 years, payable in shares, as Malaysia commits RM1 billion to digitalizing public healthcare

KUALA LUMPUR, Malaysia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) ("Company" or "BGLC") today announced plans to build AI applications for Malaysian healthcare, following the signing of a definitive agreement with Ruanyun Edai Technology Inc. (Nasdaq: RYET) on October 5, 2026 for an exclusive Malaysian healthcare licence to RYET's CogniAI artificial intelligence platform. BGLC's first target is Malaysia's public healthcare digitalization programme, which covers 150 hospitals and more than 2,000 health clinics. Closing and the

BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence

Wed, 07 Oct 2026 08:30:00 -0400

Licence of up to 20 years, payable in shares, as Malaysia commits RM1 billion to digitalizing public healthcare

BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence

Wed, 07 Oct 2026 08:30:00 -0400

Licence of up to 20 years, payable in shares, as Malaysia commits RM1 billion to digitalizing public healthcare

BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence

Wed, 07 Oct 2026 08:30:00 -0400

Licence of up to 20 years, payable in shares, as Malaysia commits RM1 billion to digitalizing public healthcare

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

Mon, 05 Oct 2026 09:00:00 -0400

License of up to 20 years and reciprocal share exchange would entitle RYET to a 10% royalty on qualifying technology receipts and 560,000 BGLC shares as Malaysia accelerates public healthcare digitalization

KUALA LUMPUR, Malaysia, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (NASDAQ: RYET) (“RYET” or the “Company”) today announced that it has signed a definitive agreement under which, on closing, RYET would grant BioNexus Gene Lab Corp. (NASDAQ: BGLC) (“BGLC”) an exclusive license of its Cogni AI document-intelligence platform for healthcare in Malaysia, together with a reciprocal share exchange. The agreement would take Cogni AI into

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

Mon, 05 Oct 2026 09:00:00 -0400

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

Mon, 05 Oct 2026 09:00:00 -0400

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

Mon, 05 Oct 2026 09:00:00 -0400

Form SCHEDULE 13D BioNexus Gene Lab Corp Filed by: Tan Lee Su-Leng

Fri, 14 Aug 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260814/26932964.html

Form SCHEDULE 13D BioNexus Gene Lab Corp Filed by: Tan Lee Su-Leng

Fri, 14 Aug 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260814/26932964.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Tan Lee Su-Leng

Fri, 14 Aug 2026 17:21:00 -0400

si-local-file:///var/storage/secattach/20260814/26932822.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Tan Lee Su-Leng

Fri, 14 Aug 2026 17:21:00 -0400

si-local-file:///var/storage/secattach/20260814/26932822.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Yap Chee Keong

Fri, 14 Aug 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260814/26932808.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Yap Chee Keong

Fri, 14 Aug 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260814/26932808.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Bin Abdul Hamid Muhammad Azrul

Fri, 14 Aug 2026 17:19:00 -0400

si-local-file:///var/storage/secattach/20260814/26932792.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Bin Abdul Hamid Muhammad Azrul

Fri, 14 Aug 2026 17:19:00 -0400

si-local-file:///var/storage/secattach/20260814/26932792.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Chong Set Fui

Fri, 14 Aug 2026 17:18:00 -0400

si-local-file:///var/storage/secattach/20260814/26932771.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Chong Set Fui

Fri, 14 Aug 2026 17:18:00 -0400

si-local-file:///var/storage/secattach/20260814/26932771.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Low Jook Yuen

Fri, 14 Aug 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260814/26932719.html

Form 4 BioNexus Gene Lab Corp For: Aug 13 Filed by: Low Jook Yuen

Fri, 14 Aug 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260814/26932719.html

Form 10-Q BioNexus Gene Lab Corp For: Jun 30

Fri, 14 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26932465.html

Form 10-Q BioNexus Gene Lab Corp For: Jun 30

Fri, 14 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26932465.html

Form 3 BioNexus Gene Lab Corp For: Nov 28 Filed by: FIDELION DIAGNOSTICS PTE. LTD.

Fri, 07 Aug 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260807/26891480.html

Form 3 BioNexus Gene Lab Corp For: Nov 28 Filed by: FIDELION DIAGNOSTICS PTE. LTD.

Fri, 07 Aug 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260807/26891480.html